Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment..
Expert Opin Ther Targets. 19(3), 299-306.
(2015).
(2021). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels..
Eur J Endocrinol. 165(1), 63-8.
(2011). Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation..
Rheumatology (Oxford). 54(5), 908-14.
(2015). Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment..
Horm Metab Res. 46(2), 145-9.
(2014). Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass..
J Musculoskelet Neuronal Interact. 19(3), 253-257.
(2019). Circulating microRNAs Related to Bone Metabolism in HIV-Associated Bone Loss..
Biomedicines. 9(4),
(2021). Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review..
In Vivo. 36(4), 1551-1569.
(2022). Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis..
J Gastroenterol Hepatol.
(2024). Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis..
Diabetologia. 59(1), 30-43.
(2016).
(2017). Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events..
Int J Obes (Lond). 39(1), 156-61.
(2015). Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months..
Osteoporos Int. 25(5), 1633-42.
(2014). Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition..
J Clin Endocrinol Metab. 99(9), 3247-55.
(2014). Circulating homocysteine in nonalcoholic fatty liver disease..
Eur J Intern Med. 26(2), 152-3.
(2015). Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans..
Metabolism. 65(10), 1459-65.
(2016). Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study..
Biomarkers. 19(8), 660-6.
(2014). Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis..
J Clin Exp Hepatol. 14(3), 101353.
(2024). Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study..
Rom J Intern Med. 57(2), 141-150.
(2019). Circulating anti-BP180 NC16a and anti-BP230 autoantibodies in patients with genital lichen sclerosus do not correlate with disease activity and pruritus..
Acta Derm Venereol. 94(6), 711-2.
(2014). Circulating angiogenic biomolecules at rest and in response to upper-limb exercise in individuals with spinal cord injury..
J Spinal Cord Med. 37(2), 226-32.
(2014). Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide..
Diabetes Res Clin Pract. 113, 125-34.
(2016). Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis..
J Gastroenterol Hepatol.
(2022). Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment..
Osteoporos Int. 24(7), 2127-32.
(2013).